Back
 Health  Vol.10 No.8 , August 2018
Does High Systolic Blood Pressure Truly Increase Medical Expenditure?—An Empirical Analysis of the New 2017 ACC/AHA Hypertension Guideline
Abstract: Background: High blood pressure (BP) or hypertension is considered one of the top global disease burden risk factors. In November 2017, the ACC/AHA and other organizations announced a new hypertension guideline of 130/80 mmHg. Data and Methods: We evaluate the effects of BP on increases in medical expenditures using transformation tobit models and a dataset containing 175,123 medical checkups and 6,312,125 receipts from 88,211 individuals in three health insurance societies. The sample period was April 2013 to March 2016. We first created a database of combined checkup results and medical expenditures. The power transformation tobit model was then used to remove the effects of other variables, and we investigated the relation between medical expenditures and BP, especially systolic BP (SBP). Results: We observed negative effects of SBP on medical expenditures. The results raise uncertainty about the reliability of the new guideline, at least for SBP. Although the simple correlation coefficient of medical expenditures and SBP was positive, the sign of the SBP estimate became negative when a variable representing obesity was included. In terms of other medical checkup items, while LDL is considered the “bad” cholesterol, it reduced medical expenditures. Conclusion: Our results did not support the new 2017 ACC/AHA guideline for SBP. A wide and careful range of reviews not only for heart diseases but also for other disease types will be absolutely necessary. New studies to verify the guideline should also be conducted. Limitations: The dataset was observatory, the sample period only 3 years, and we could not complete a time-series analysis of individuals.
Cite this paper: Nawata, K. , Kimura, M. (2018) Does High Systolic Blood Pressure Truly Increase Medical Expenditure?—An Empirical Analysis of the New 2017 ACC/AHA Hypertension Guideline. Health, 10, 1044-1065. doi: 10.4236/health.2018.108079.
References

[1]   World Health Organization (WHO) (2013) Obesity, High Blood Pressure, High Cholesterol, Alcohol and Tobacco: The World Health Organization’s Response. World Health Report.
http://www.who.int/whr/media_centre/factsheet3/en/

[2]   WHO (2016) Raised Blood Pressure.
http://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/

[3]   WHO (2013) A Global Brief on Hypertension.
http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/en/

[4]   Lim, S.S., Vos, T., Flaxman, A.D., et al. (2012) A Comparative Risk Assessment of Burden of Disease and Injury Attributable to 67 Risk Factors and Risk Factor Clusters in 21 Regions, 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2224-2260.
https://doi.org/10.1016/S0140-6736(12)61766-8

[5]   Blood Pressure Association, UK (2008) Blood Pressure Chart for Adults.
http://www.bloodpressureuk.org/BloodPressureandyou/Thebasics/Bloodpressurechart

[6]   Wohlfahrt, P., Cifková, R., Movsisyan, N., et al. (2016) Threshold for Diagnosing Hypertension by Automated Office Blood Pressure Using Random Population. Journal of Hypertension, 2180-2186.
https://doi.org/10.1097/HJH.0000000000001076

[7]   Omiboni, S., Aristizabal, D., De la Sierra, A., et al. (2016) Hypertension Types Defined by Clinic and ambulatory Blood Pressure in 14142 Patients Referred to Hypertension Clinics Worldwide. Data from ARTEMIS Study. Journal of Hypertension, 34, 2187-2198.
https://doi.org/10.1097/HJH.0000000000001074

[8]   AACN Practice Alert (2016) Obtaining Accurate Noninvasive Blood Pressure Measurements in Adults. Critical Care Nurse, 36, e12-e16.
https://doi.org/10.4037/ccn2016590

[9]   Nawata, K. and Kimura, M. (2017) Reliability of Blood Pressure Measurements: An Analysis of the White Coat Effect and Its Fluctuations. Health, 9, 506-519.
https://doi.org/10.4236/health.2017.93036

[10]   National Heart, Lung and Blood Institute, US Department of Health & Human Services (2015) Description of High Blood Pressure.

[11]   Vasan, S.R., Larson, M.G., Leip, E.P., et al. (2001) Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease. New England Journal of Medicine, 345, 1291-1297.
https://doi.org/10.1056/NEJMoa003417

[12]   Fujiyoshi, A., Ohkubo, T., Miura, K., et al. (2012) Blood Pressure Categories and Log-Term Risk of Cardiovascular Disease According to Age Group in Japanese Men and Women. Hypertension Research, 35, 947-953.
https://doi.org/10.1038/hr.2012.87

[13]   Guidelines Subcommittee (1999) 1999 World Health Organization - International Society of Hypertension Guidelines for Management of Hypertension. Journal of Hypertension, 17, 151-183.

[14]   Prospective Studies Collaboration (2002) Age-Specific Relevance of Usual Blood Pressure to Vascular Mortality: A Meta-Analysis of Individual Data for One Million Adults in 61 Prospective Studies. Lancet, 360, 1903-1913.
https://doi.org/10.1016/S0140-6736(02)11911-8

[15]   Blanchflower, D.G. and Oswald, A.J. (2008) Hypertension and Happiness across Nations. Journal of Health Economics, 27, 218-233.
https://doi.org/10.1016/j.jhealeco.2007.06.002

[16]   Mojon-Azzi, S. and Sousa-Pazo, A. (2011) Hypertension and Life Satisfaction: An Analysis Using Data from the Survey of Health, Aging and Retirement in Europe. Applied Economics Letters, 18, 183-187.
https://doi.org/10.1080/13504850903508291

[17]   World Health Organization, International Society of Hypertension Writing Group (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) Statement on Management of Hypertension. Journal of Hypertension, 11, 1983-1992.

[18]   Gaziano, T.A., Bitton, A., Anand, S., et al. (2009) The Global Cost of Nonoptimal Blood Pressure. Journal of Hypertension, 27, 1472-1477.
https://doi.org/10.1097/HJH.0b013e32832a9ba3

[19]   Benjamin, E.J., Blaha, M.J., Chiuve, S.E., et al. (2017) Heart Disease and Stroke Statistics—2017 Updates: A Report from the American Heart Association. Circulation, 135, e146-e603.
https://doi.org/10.1161/CIR.0000000000000485

[20]   Wang, G., Grosse, G.S.D. and Schooley, M.W. (2017) Conducting Research on the Economics of Hypertension to Improve Cardiovascular Health. American Journal of Preventive Medicine, 53, S115-S117.
https://doi.org/10.1016/j.amepre.2017.08.005

[21]   Centers for Disease Control and Prevention (CDC) (2016) High Blood Pressure Fact Sheet.
https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm

[22]   Ministry of Health, Welfare, and Labor (2017) Heisei 27 nendo kokumin iryouhi no gayou (Summary of National Medical Expenditures). (In Japanese)

[23]   Ibrahim, M.M. and Damasceno, A. (2012) A Hypertension in Developing Countries. The Lancet, 380, 611-619.
https://doi.org/10.1016/S0140-6736(12)60861-7

[24]   Gorman, B.K. and Porter, J.R. (2011) Social Networks and Support, Gender, and Radical/Ethic Disparities in Hypertension among Older Adults. Population Research & Policy Review, 20, 885-911.
https://doi.org/10.1007/s11113-011-9215-4

[25]   Rose, G. (2001) Sick Individuals and Sick Populations. International Journal of Epidemiology, 30, 427-432.
https://doi.org/10.1093/ije/30.3.427

[26]   Nawata, K., Matsumoto, A., Kajihara, K., et al. (2017) Evaluation of the Distribution of and Factors Affecting Blood Pressure Using Medical Checkup Data in Japan. Health, 9, 124-137.
https://doi.org/10.4236/health.2017.91009

[27]   Surfstat.australia: An Online text in Introductory Statistics (2018) Summarising and Presenting Data, Normal Distributions.
https://surfstat.anu.edu.au/surfstat-home/1-3-1.html

[28]   Whelton, P.K., Carey, R.M., Arrow, W.S., et al. (2018) 2017 ACC/AHA/AAPA/ABC /ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 71, e13-e115.

[29]   Whelton, P.K., Carey, R.M., Arrow, W.S., et al. (2018) 2017 Guild Line for Blood Pressure in Adults. American College of Cardiology.
http://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/11/09/11/41/2017-guideline-for-high-blood-pressure-in-adults

[30]   Carey, R.M. and Whelton, P.K. for the 2017 ACC/AHA Hypertension Guideline Writing Committee (2018) Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Annals of Internal Medicine, 168, 351.
https://doi.org/10.7326/M17-3203

[31]   American Academy of Family Physicians (AAFP) (2017) AAFP Decides to Not Endorse AHA/ACC Hypertension Guideline, Academy Continues to Endorse JNC8 Guideline. AAFP News.
https://www.aafp.org/news/health-of-the-public/20171212notendorseaha-accgdlne.html

[32]   Wright, J.T., Williamson, J.D., Whelton, P.K., et al. (2015) A Randomized Trial of Intensive versus Standard Blood-Pressure Control. New England Journal of Medicine, 373, 2103-2116.
https://doi.org/10.1056/NEJMoa1511939

[33]   Nawata, K., Sekizawa, Y. and Kimura, M. (2018) Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials. Health, 10, 587-603.
https://doi.org/10.4236/health.2018.105047

[34]   Dickersin, K., Chan, S.S, Chalmersx, T.C., et al. (1987) Publication Bias and Clinical Trials. Controlled Clinical Trials, 8, 343-353.
https://doi.org/10.1016/0197-2456(87)90155-3

[35]   Hopewell, S., Loudon, K., Clarke, M.J., et al. (2009) Publication Bias in Clinical Trials Due to Statistical Significance or Direction of Trial Results. Cochrane Database of Systematic Reviews, No. 1, MR000006.
http://sverigesradio.se/diverse/appdata/isidor/files/83/5775.pdf

[36]   Turner, E.H., Matthews, A.M., Linardatos, E., et al. (2008) Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. New England Journal of Medicine, 358, 252-260.
https://doi.org/10.1056/NEJMsa065779

[37]   Lexchin, J., Bero, L.A., Djulbegovic, B.B., et al. (2003) Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review. BMJ, 326, 1167.
https://doi.org/10.1136/bmj.326.7400.1167

[38]   Perlis, R.H., Perlis, C.S., Wu, Y., et al. (2005) Industry Sponsorship and Financial Conflict of Interest in the Reporting of Clinical Trials in Psychiatry. American Journal of Psychiatry, 162, 1957-1960.
https://doi.org/10.1176/appi.ajp.162.10.1957

[39]   Lundh, A., Lexchin, J., Mintzes, B., et al. (2017) Industry Sponsorship and Research Outcome. Cochrane Database of Systematic Reviews, No. 12, MR000033.
http://cochranelibrary-wiley.com/doi/10.1002/14651858.MR000033.pub3/full
https://doi.org/10.1002/14651858.MR000033.pub3


[40]   Park, T.R., Rodriguez, D.M. and Roth, F.P. (2015) Why Clinical Trials Are Terminated.
https://www.biorxiv.org/content/biorxiv/early/2015/07/02/021543.full.pdf

[41]   The ACCORD Study Group (2010) Effect of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. New England Journal of Medicine, 362, 1575-1585.
https://doi.org/10.1056/NEJMoa1001286

[42]   Nawata, K. and Kimura, M. (2017) Evaluation of Medical Costs of Kidney Diseases and Risk Factors in Japan. Health, 9, 1734-1749.
https://doi.org/10.4236/health.2017.913127

[43]   Gregori, D., Petrinco, M., Simona, B., et al. (2011) Regression Models for Analyzing Costs and Their Determinants in Health Care: An Introductory Review. International Journal for Quality in Health Care, 23, 331-341.
https://doi.org/10.1093/intqhc/mzr010

[44]   Japanese Law Translation (2009) Industrial Safety and Health Act.
http://www.japaneselawtranslation.go.jp/law/detail/?id=1926&vm=&re

[45]   Health Insurance Claims Review & Reimbursement Services (2018) Sinsa joukyou heisei 30 nen 3 gatsu (Results of Checking, March 2018). (In Japanese)

[46]   Nawata, K., Ii, M., Toyama, H., et al. (2009) Evaluation of the Inclusive Payment System Based on the Diagnosis Procedure Combination with Respect to Cataract Operations in Japan. Health, 1, 93-103.
https://doi.org/10.4236/health.2009.12016

[47]   Deng, L., Lou, W. and Mitsakakis, N. (2018) Modeling Right-Censored Medical Cost Data in Regression and the Effects of Covariates. Statistical Methods & Applications, 1-13.
https://doi.org/10.1007/s10260-018-0428-0

[48]   Amemiya, T. (1985) Advanced Econometrics. Harvard University Press, Cambridge.

[49]   Box, G.E.P. and Cox, D.R. (1964) An Analysis of Transformation. Journal of the Royal Statistical Society B, 26, 211-252.

[50]   Nawata, K. (1994) Estimation of Sample Selection Bias Models by the Maximum Likelihood Estimator and Heckman’s Two-Step Estimator. Economic Letters, 45, 33-40.
https://doi.org/10.1016/0165-1765(94)90053-1

[51]   Nawata, K. and Kimura, M. (2017) An Analysis of the Medical Costs of and Factors Affecting Diabetes Using the Medical Checkup and Payment Dataset in Japan: Can We Reduce the Prevalence of Diabetes? Health, 9, 1113-1127.
https://doi.org/10.4236/health.2017.98081

[52]   CDC (2017) LDL and HDL Cholesterol: “Bad” and “Good” Cholesterol.
https://www.cdc.gov/cholesterol/ldl_hdl.htm

[53]   American Heart Association (AEA) (2017) HDL (Good), LDL (Bad) Cholesterol and Triglycerides.
http://www.heart.org/HEARTORG/Conditions/Cholesterol/HDLLDLTriglycerides/HDL-Good-LDL-Bad-Cholesterol-and-Triglycerides_UCM_305561_Article.jsp#.WxUKUkjRCUk

[54]   AEA (2017) About Cholesterol.
http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/About-Cholesterol_UCM_001220_Article.jsp#.Wtrw2ojFKUk

[55]   WHO (2018) Raised Cholesterol.
http://www.who.int/gho/ncd/risk_factors/cholesterol_text/en/

[56]   U.S. National Library of Medicine (2018) Medical Encyclopedia.
https://medlineplus.gov/encyclopedia.html

[57]   Muntner, P., Carey, R.M., Gidding, S., et al. (2018) Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Journal of the American College of Cardiology, 71, 109-118.
https://doi.org/10.1016/j.jacc.2017.10.073

[58]   Kennel, W.B., Brand, N., Skinner, J.J., et al. (1967) The Relation of Adiposity to Blood Pressure and Development of Hypertension: The Framingham Study. Annals of Internal Medicine, 67, 48-59.
https://doi.org/10.7326/0003-4819-67-1-48

[59]   Kotchen, T.A. (2010) Obesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management. American Journal of Hypertension, 23, 1170-1178.
https://doi.org/10.1038/ajh.2010.172

[60]   Jiang, S.-Z., Lu, W., Zong, X.-F., et al. (2016) Obesity and Hypertension. Experimental and Therapeutic Medicine, 12, 2395-2399.
https://doi.org/10.3892/etm.2016.3667

[61]   Loggi, M., Lombardi, M. and Caldarone, E. (2017) The Relationship between Obesity and Hypertension: An Comprehensive Overviews on Twins. Hypertension Research, 40, 947-963.
https://doi.org/10.1038/hr.2017.75

[62]   The National Institute of Diabetes and Digestive and Kidney Diseases, Health Information Center (2014) Blood Pressure & Kidney Disease, What Is High Blood Pressure?
https://www.niddk.nih.gov/health-information/kidney-disease/high-blood-pressure

 
 
Top